speb/financial-data huggingface dataset:
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -517102000.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -95721000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 515775000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 515775000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1204520000.00
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 339545000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 105116000.00
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 27309000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 3782000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 3782000.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -3202000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1183954000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1183954000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 3168188000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3168188000.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 291530000.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2272000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 51145000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 74105000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Share Issued: 36630701.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 36630701.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Special Income Charges: -1014000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5006586000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5006586000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5006503000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5006503000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Tax Provision: 86943000.00
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 14517000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2423000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2423000.00
CHEMCON.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -26423000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Assets: 5539398000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 5539398000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5008449000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5008449000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Debt: 246899000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 246899000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5006586000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5006586000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Total Expenses: 1850555000.00
CHEMCON.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 518389000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 532812000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 532812000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2348979000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2348979000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 55951000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 55951000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 437000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -285000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -285000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Work In Process: 44779000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 44779000.00
CHEMCON.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2713558000.00
CHEMCON.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2713558000.00
CHEMCON.NS income_statement (annual, 2025-03-31) — Write Off: 608000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 169948000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 535180000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 36707471.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.74
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 314692000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 27242000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 27242000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 36707471.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.74
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — EBIT: 87703000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — EBITDA: 114945000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 220488000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 3400000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3400000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -3400000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3400000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 114945000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 63871000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Operating Income: 50540000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 535180000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 37169000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 92940000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 84303000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 314692000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 27242000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 20432000.00
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
CHEMCON.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 484640000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 154188000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 537142000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 194551000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 575563000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 868245000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 36601911.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.57
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 366307000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 190125000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1254813000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 366307000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5126910000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 465371000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 342067000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2674107000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1532000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1532000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 292923000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3887000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 27676000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 27676000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 36601911.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.57
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — EBIT: 80354000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — EBITDA: 108030000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 56000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1907145000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 195075000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 932000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 932000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 756316000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5129526000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 868245000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1084000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1084000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 10300000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -932000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -932000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1907145000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5126854000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 46669000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 108030000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 57465000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Operating Income: 40887000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 537142000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 36630701.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 87415000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 18731000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4760603000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1384000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 39467000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 77093000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1441774000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1064688000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Payables: 196145000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 79422000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 342067000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 27676000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 36630701.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5126910000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5126854000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 21957000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.28
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 5477886000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5127994000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2616000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5126910000.00
CHEMCON.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 496255000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 350976000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2803779000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 58053000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1594000.00
CHEMCON.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2381184000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 156904000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 573250000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 36642446.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.39
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 378071000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 28225000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 28225000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 36642446.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.39
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — EBIT: 74610000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — EBITDA: 102835000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 195179000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 6673000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6673000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -6673000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6673000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 102835000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 50933000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Operating Income: 38275000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 573250000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 36335000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 80330000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 67937000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 378071000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 28225000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 17004000.00
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CHEMCON.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 534975000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — +Operating Expense: 654743000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 173699000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — +Total Revenue: 2399789000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 754217000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 179066000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 179066000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 635440000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 635440000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 37316000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 37316000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 36643168.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 36616667.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Basic EPS: 6.44
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.74
CHEMCON.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 71229000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -91915000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 366307000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 366307000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 103862000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 103862000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2049758000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2049758000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 239825000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 153764000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 5025000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Payable: -142446000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -81791000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 173515000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 32633000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Common Stock: 366307000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 366307000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 4831402000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4831402000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 208728000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 208728000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1558857000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 524026000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3460099000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3460099000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Current Debt: 530580000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 530580000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 530580000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 530580000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 784922000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 784922000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 3161000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 3161000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Depreciation: 115532000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 115532000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 115532000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 32390000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 115532000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 32390000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 36643168.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 36616667.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Diluted EPS: 6.44
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.74
CHEMCON.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — EBIT: 340716000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — EBIT: 98047000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — EBITDA: 456248000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — EBITDA: 130437000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — End Cash Position: 103862000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -29919000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 323548000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -5571000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -249000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 33000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 33000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2155135000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2155135000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Gross Profit: 840932000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 230191000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Interest Expense: 21129000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 10121000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 21129000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 10121000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -21129000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 106354000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Inventory: 672658000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 672658000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 5362770000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5362770000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -352911000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 37316000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 37316000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 788000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 788000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 788000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 788000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 3307000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 3307000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -356418000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Net Debt: 427506000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 427506000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -7712000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 63713000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 319587000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 63713000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Interest Income: -21129000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -10121000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -20165000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -8790000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -137386000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -21129000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -10121000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 8509000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2155135000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2155135000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -91191000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 128596000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4831369000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4831369000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 55364000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 55364000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 456248000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 130437000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Normalized Income: 235982000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 63713000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 415463000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Operating Income: 186189000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Operating Income: 56492000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Operating Revenue: 2399789000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 754217000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 36630701.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 36630701.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 95777000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 95777000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 38170000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 38170000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 4465095000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 4465095000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -102873000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1187000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1187000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 3866000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 3866000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 154527000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 41555000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 338581000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 88212000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1946407000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1946407000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1945896000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1945896000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Payables: 179066000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Payables: 179066000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Pretax Income: 319587000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 87926000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -356418000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -459075000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -91915000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1558857000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 524026000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 115532000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 32390000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 438910000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 724000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Share Issued: 36630701.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 36630701.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 4831402000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4831402000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4831369000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4831369000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Tax Provision: 83605000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 24213000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.28
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 6466000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 6466000.00
CHEMCON.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -76766000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5679649000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5679649000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 4832190000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4832190000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Debt: 531368000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 531368000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 4831402000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4831402000.00
CHEMCON.NS income_statement (annual, 2026-03-31) — Total Expenses: 2213600000.00
CHEMCON.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 697725000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 848247000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 848247000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2219550000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2219550000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 63325000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 63325000.00
CHEMCON.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2675177000.00
CHEMCON.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2675177000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -721100000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 14249800000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 148563579.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Basic EPS: 43.66
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2312800000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 9449800000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 547700000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 13000000000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 148563579.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Diluted EPS: 43.66
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 400000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 494300000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Fixed Assets Revaluation Reserve: 15992800000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: 0.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 328800000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Interest Income: 338600000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 338600000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 13000000000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 11728900000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 112400000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 19269400000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 13000000000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 522500000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 126500000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 269600000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 4012050000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Other Payable: 761100000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 845000000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 39600000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 464400000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 6499100000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 34200000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 34200000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 2080300000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 16503600000.00
CHEMPLASTS.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 546100000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 874900000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 822300000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 158000000.00
CHEMPLASTS.NS balance_sheet (annual, 2022-03-31) — Work In Process: 117100000.00
CHEMPLASTS.NS income_statement (annual, 2022-03-31) — Write Off: -100000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 12294800000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 49345300000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 18615300000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1426400000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1999100000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 14255300000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 100000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 158109574.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Basic EPS: 9.64
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 9997500000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2404000000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4195900000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 112400000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 790600000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 11109800000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 11300000000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 8538500000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2571300000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -125500000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Change In Payable: -118400000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 121400000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -122500000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 1112300000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 790600000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 18584600000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 4483400000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 33116900000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 21456600000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 32700000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 785500000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 818200000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 22343500000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 13400000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Depreciation: 1420000000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1420000000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1420000000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1420000000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 158109574.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 9.64
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — EBIT: 2437700000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — EBITDA: 3857700000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 11109800000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 400000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -269900000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 358300000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Fixed Assets Revaluation Reserve: 15558300000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -641600000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 23600000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -200000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 507500000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 38341700000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Gross Profit: 16228400000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Interest Expense: 722600000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 722600000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Interest Income: 643100000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 643100000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1636000000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 649100000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Inventory: 6431000000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 28664300000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -2172100000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 500000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2110000000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 11742800000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 79700000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 9294200000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 9373900000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2110000000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -593000000.00
CHEMPLASTS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 19711500000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -103500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1523500000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1715100000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1523500000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -897100000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1517000000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1517000000.00
CHEMPLASTS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -897100000.00
CHEMPLASTS.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1374400000.00